Linking the Plasma Proteome to Echocardiographic Parameters in Patients with Chronic Heart Failure
Explore the role of high-plex proteomics in providing deeper insights into heart failure pathophysiology
Recent advancements in proteomic profiling have unlocked new possibilities for understanding the complex mechanisms that drive heart failure
Measuring thousands of proteins simultaneously makes it possible to capture a comprehensive overview of the patient’s health state and investigate underlying disease progression at a subclinical level.
Webinar highlights:
- How the SomaScan™ Assay was used to measure 4,210 plasma proteins in 173 patients with heart failure over a median follow-up of 2.7 years, revealing significant associations with echocardiographic parameters
- How to understand the diverse pathways involved in cardiac disfunction by performing distinct associations between specific proteins and echocardiographic parameters
- How these proteomic insights can inform the development of targeted therapies and improve risk stratification in chronic heart failure patients
Isabella Kardys, MD, PhD
Erasmus University Medical Center
Isabella Kardys is a professor of translational cardiovascular epidemiology at Erasmus University Medical Center where she leads a research line focused on innovative methodological approaches in clinical epidemiological studies of acquired heart disease, particularly emphasizing serially measured blood biomarkers.
Linking the Plasma Proteome to Echocardiographic Parameters in Patients with Chronic Heart Failure
A presentation by Isabella Kardys, MD, PhD
More webinars
WebinarB Cell Repertoire in Determining Responses to Checkpoint Blockade in NSCLC
In this webinar, Gary Middleton, MD, PhD, and Akshay Patel, PhD, from the University of Birmingham explore the role of the B cell repertoire and autoantibodies in shaping responses to checkpoint blockade immunotherapy in non-small-cell lung cancer (NSCLC). They demonstrate how autoantibody profiling using the i-Ome™ Discovery protein microarray revealed biomarkers predictive of treatment efficacy and immune-related adverse events (irAEs), providing insights into biomarker development and personalized immunotherapy strategies.
WebinarSerum Autoantibodies Differentiate Rheumatoid Arthritis Subgroups
Patients with rheumatoid arthritis (RA) can be categorized as either anti-citrullinated protein antibody-positive (ACPA+) or negative (ACPA-). In this webinar, Dr. Sung will present his research exploring a broad range of serological autoantibodies to uncover immunological differences between these RA subgroups using data from ACPA+ RA patients, ACPA- RA patients, and matched healthy controls.
WebinarData Summit 2025
Take your research further with expert insights from the SomaScan™ Data Summit. Explore the latest platform updates, advanced data analysis tools, and innovative applications for SOMAmer™ reagents. From optimizing sample quality to customizing panels beyond 7K and 11K, this event is packed with knowledge to help you get the most from your data.